RSQ-002 - CT-Luso – Ethics and regulatory capacity building partnership for clinical trials in Portuguese-speaking African countries

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: RSQ-002
• By: MORIM, Diogo
• Co-author(s): Prof. Dr. Maria do Céu Patrão Neves (CT-Luso Coordination Team, Portuguese Pharmaceutical Society, Lisbon, Portugal)
  Prof. Dr. Maria Alexandra Ribeiro (CT-Luso Coordination Team, Portuguese Pharmaceutical Society, Lisbon, Portugal)
  Dr. Catarina Sobrinho (CT-Luso Project Manager, Portuguese Pharmaceutical Society, Lisbon, Portugal)
  Dr. Ana Elisabete Ferreira (Lawyers and Researchers, Center for Biomedical Law, Faculty of Law of the University of Coimbra, Coimbra, Portugal)
  Dr. André Dias Pereira (Lawyers and Researchers, Center for Biomedical Law, Faculty of Law of the University of Coimbra, Coimbra, Portugal)
  Dr. Carla Barbosa (Lawyers and Researchers, Center for Biomedical Law, Faculty of Law of the University of Coimbra, Coimbra, Portugal)
  Dr. Daniela Marques (Lawyers and Researchers, Center for Biomedical Law, Faculty of Law of the University of Coimbra, Coimbra, Portugal)
  Dr. Walter Van-Trier (Lawyer, Ministry of Health, Luanda, Angola)
  Dr. João Semedo (Lawyer, ERIS, Praia, Cape Verde)
  Dr. Miguel Pereira (Lawyer, Ministry of Health, Bissau, Guinea-Bisau)
  Dr. Virgílio Uamba (Lawyer, ANARME, Maputo, Mozambique)
  Dr. Bernardett Santos (Lawyer, Ministry of Health, São Tomé, São Tomé and Príncipe)
  Dr Diogo Morim (International Affairs, Portuguese Pharmaceutical Society, Lisbon, Portugal)
  Prof. Dr. Helder Mota Filipe (CT-Luso Coordination Team, Portuguese Pharmaceutical Society, Lisbon, Portugal / President, Portuguese Pharmaceutical Society, Lisbon, Portugal)
  
• Abstract:

  Introduction
  Africa offers excellent opportunities for conducting Clinical Trials (CT), particularly due to its epidemiological and genetic diversity. However, only 3,3% of global clinical trials take place on the continent. Several barriers hinder the conduct of CTs and the attraction of international investment, including ethical and legal gaps, ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login